98 related articles for article (PubMed ID: 9352579)
1. CYP2D6 genotype and smoking behaviour in cigarette smokers.
Boustead C; Taber H; Idle JR; Cholerton S
Pharmacogenetics; 1997 Oct; 7(5):411-4. PubMed ID: 9352579
[No Abstract] [Full Text] [Related]
2. Effect of genotype and methylation of CYP2D6 on smoking behaviour.
Tiili EM; Antikainen MS; Mitiushkina NV; Sukhovskaya OA; Imyanitov EN; Hirvonen AP
Pharmacogenet Genomics; 2015 Nov; 25(11):531-40. PubMed ID: 26287939
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 genotypes in cigarette smokers and non-tobacco users.
Cholerton S; Boustead C; Taber H; Arpanahi A; Idle JR
Pharmacogenetics; 1996 Jun; 6(3):261-3. PubMed ID: 8807667
[No Abstract] [Full Text] [Related]
4. CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour.
Saarikoski ST; Sata F; Husgafvel-Pursiainen K; Rautalahti M; Haukka J; Impivaara O; Järvisalo J; Vainio H; Hirvonen A
Pharmacogenetics; 2000 Feb; 10(1):5-10. PubMed ID: 10739167
[TBL] [Abstract][Full Text] [Related]
5. CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships.
Laforest L; Wikman H; Benhamou S; Saarikoski ST; Bouchardy C; Hirvonen A; Dayer P; Husgafvel-Pursiainen K
Eur J Cancer; 2000 Sep; 36(14):1825-32. PubMed ID: 10974631
[TBL] [Abstract][Full Text] [Related]
6. Nicotine metabolism and CYP2D6 phenotype in smokers.
Caporaso NE; Lerman C; Audrain J; Boyd NR; Main D; Issaq HJ; Utermahlan B; Falk RT; Shields P
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):261-3. PubMed ID: 11303596
[TBL] [Abstract][Full Text] [Related]
7. Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.
Ellingrod VL; Schultz SK; Arndt S
Pharmacotherapy; 2002 Nov; 22(11):1416-9. PubMed ID: 12432967
[TBL] [Abstract][Full Text] [Related]
8. Effects of CYP2D6 activity and tobacco on larynx cancer risk.
Benhamou S; Bouchardy C; Paoletti C; Dayer P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):683-6. PubMed ID: 8877058
[TBL] [Abstract][Full Text] [Related]
9. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
Berecz R; de la Rubia A; Dorado P; Fernández-Salguero P; Dahl ML; LLerena A
Eur J Clin Pharmacol; 2003 May; 59(1):45-50. PubMed ID: 12682803
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 genotype and the incidence of anal and vulvar cancer.
Chen C; Cook LS; Li XY; Hallagan S; Madeleine MM; Daling JR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):317-21. PubMed ID: 10207635
[TBL] [Abstract][Full Text] [Related]
11. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.
Bock KW; Schrenk D; Forster A; Griese EU; Mörike K; Brockmeier D; Eichelbaum M
Pharmacogenetics; 1994 Aug; 4(4):209-18. PubMed ID: 7987405
[TBL] [Abstract][Full Text] [Related]
12. Correspondence re: C. Chen et al., CYP2D6 genotype and the incidence of anal and vulvar cancer. Cancer Epidemiol. Biomark. Prev., 8: 317-321, 1999.
Hecht SS
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):839-40. PubMed ID: 10498405
[No Abstract] [Full Text] [Related]
13. Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio.
Ohara K; Tanabu S; Yoshida K; Ishibashi K; Ikemoto K; Shibuya H
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):945-9. PubMed ID: 14499311
[TBL] [Abstract][Full Text] [Related]
14. The genetics of nicotine dependence: relationship to pancreatic cancer.
MacLeod SL; Chowdhury P
World J Gastroenterol; 2006 Dec; 12(46):7433-9. PubMed ID: 17167830
[TBL] [Abstract][Full Text] [Related]
15. CYP2D6 poor metabolizer genotype and smoking predict severe postoperative pain in female patients on arrival to the recovery room.
Yang Z; Yang Z; Arheart KL; Morris R; Zhang Y; Rodriguez Y; Song C; Gitlin MC; Candiotti KA
Pain Med; 2012 Apr; 13(4):604-9. PubMed ID: 22497725
[TBL] [Abstract][Full Text] [Related]
16. Comparison of recent trends in adolescent and adult cigarette smoking behaviour and brand preferences.
Cummings KM; Hyland A; Pechacek TF; Orlandi M; Lynn WR
Tob Control; 1997; 6 Suppl 2(Suppl 2):S31-7. PubMed ID: 9583650
[TBL] [Abstract][Full Text] [Related]
17. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
Carter B; Long T; Cinciripini P
Nicotine Tob Res; 2004 Apr; 6(2):221-7. PubMed ID: 15203795
[TBL] [Abstract][Full Text] [Related]
18. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
Chu SL; Xiao D; Wang C; Jing H
Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
[TBL] [Abstract][Full Text] [Related]
19. The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population.
Johnstone EC; Yudkin P; Griffiths SE; Fuller A; Murphy M; Walton R
Addict Biol; 2004; 9(3-4):221-6. PubMed ID: 15511716
[TBL] [Abstract][Full Text] [Related]
20. Does High Tobacco Consumption Cause Psychological Distress? A Mendelian Randomization Study.
Skov-Ettrup LS; Nordestgaard BG; Petersen CB; Tolstrup JS
Nicotine Tob Res; 2017 Jan; 19(1):32-38. PubMed ID: 27613883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
